Viral oncogenesis and its role in nonmelanoma skin cancer

British Journal of Dermatology

Volumn 164, Issue 6, 2011, Pages 1201-1213

  Tuttleton Arron, S ^a   Jennings, L ^b   Nindl, I ^c   Rosl, F ^c   Bouwes Bavinck, J N ^d   Seckin D ^e   Trakatelli, M ^f   Murphy, G M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BEAUMONT HOSPITAL   (Ireland)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e BASKENT UNIVERSITY   (Turkey)

^f ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CIDOFOVIR; DOXORUBICIN; GANCICLOVIR; IMATINIB; INTERLEUKIN 12; SORAFENIB; SUNITINIB; VALGANCICLOVIR; VALPROIC ACID;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; MERKEL CELL TUMOR; ONCOVIRINAE; PAPILLOMA VIRUS; POLYOMA VIRUS; PRIORITY JOURNAL; REVIEW; SKIN CANCER; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET RADIATION; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION;

CARCINOMA, MERKEL CELL; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; FORECASTING; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; PAPILLOMAVIRUS INFECTIONS; POLYOMAVIRUS INFECTIONS; SARCOMA, KAPOSI; SKIN NEOPLASMS; TUMOR VIRUS INFECTIONS; ULTRAVIOLET RAYS;

EID: 79957627438     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10322.x     Document Type: Review

References (174)

1. Kaslow RA, Evans AS,. Epidemiologic concepts and methods. In: Viral Infections of Humans: Epidemiology and Control (, Evans AS, Kaslow RA, eds), 4th edn, Vol. 1. New York: Plenum Publishing Corporation, 1997; 3-58.
2. Hanahan D, Weinberg RA,. The hallmarks of cancer. Cell 2000; 100: 57-70. (Pubitemid 30046295)
3. Singh S, Kaye S, Gore ME, et al. The role of human endogenous retroviruses in melanoma. Br J Dermatol 2009; 161: 1225-31.
4. Mirvish ED, Pomerantz RG, Geskin LJ,. Infectious agents in cutaneous T-cell lymphoma. J Am Acad Dermatol 2011; 64: 423-31.
5. Nicot C,. Current views in HTLV-I-associated adult T-cell leukemia/lymphoma. Am J Hematol 2005; 78: 232-9. (Pubitemid 40316504)
6. Ferreri AJ, Ernberg I, Copie-Bergman C,. Infectious agents and lymphoma development: molecular and clinical aspects. J Intern Med 2009; 265: 421-38.
7. zur Hausen H,. The search for infectious causes of human cancers: where and why. Virology 2009; 392: 1-10.
8. Butel JS,. Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. Carcinogenesis 2000; 21: 405-26. (Pubitemid 30137926)
9. Kung HJ, Boerkoel C, Carter TH,. Retroviral mutagenesis of cellular oncogenes: a review with insights into the mechanisms of insertional activation. Curr Top Microbiol Immunol 1991; 171: 1-25.
10. Chatterjee M, Osborne J, Bestetti G, et al. Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science 2002; 298: 1432-5. (Pubitemid 35346145)
11. Galluzzi L, Kepp O, Morselli E, et al. Viral strategies for the evasion of immunogenic cell death. J Intern Med 2010; 267: 526-42.
12. zur Hausen H,. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol 1994; 186: 131-56. (Pubitemid 24099089)
13. Bradford-Hill A,. The environment and disease: association or causation? Proc R Soc Med 1965; 9: 295-300.
14. Storey A, Thomas M, Kalita A, et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 1998; 393: 229-34. (Pubitemid 28261713)
15. Bastiaens MT, ter Huurne JA, Kielich C, et al. Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. Am J Hum Genet 2001; 68: 884-94. (Pubitemid 32289734)
16. Box NF, Duffy DL, Irving RE, et al. Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma. J Invest Dermatol 2001; 116: 224-9. (Pubitemid 32173725)
17. Han J, Kraft P, Colditz GA, et al. Melanocortin 1 receptor variants and skin cancer risk. Int J Cancer 2006; 119: 1976-84. (Pubitemid 44356860)
18. Laing ME, Dicker P, Moloney FJ, et al. Association of methylenetetrahydrofolate reductase polymorphism and the risk of squamous cell carcinoma in renal transplant patients. Transplantation 2007; 84: 113-16. (Pubitemid 47094650)
19. Foster CB, Lehrnbecher T, Samuels S, et al. An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus. Blood 2000; 96: 2562-7.
20. Khan MJ, Castle PE, Lorincz AT, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 2005; 97: 1072-9. (Pubitemid 41417924)
21. Matsunaga T, Hieda K, Nikaido O,. Wavelength dependent formation of thymine dimers and (6-4) photoproducts in DNA by monochromatic ultraviolet light ranging from 150 to 365 nm. Photochem Photobiol 1991; 54: 403-10.
22. Freeman SE, Hacham H, Gange RW, et al. Wavelength dependence of pyrimidine dimer formation in DNA of human skin irradiated in situ with ultraviolet light. Proc Natl Acad Sci USA 1989; 86: 5605-9. (Pubitemid 19185593)
23. Beissert S, Granstein RD,. UV-induced cutaneous photobiology. Crit Rev Biochem Mol Biol 1996; 31: 381-404. (Pubitemid 27024211)
24. Beissert S, Loser K,. Molecular and cellular mechanisms of photocarcinogenesis. Photochem Photobiol 2008; 84: 29-34. (Pubitemid 350265103)
25. Andre N, Roquelaure B, Conrath J,. Molecular effects of cyclosporine and oncogenesis: a new model. Med Hypotheses 2004; 63: 647-52. (Pubitemid 39485832)
26. Ducloux D, Carron PL, Rebibou JM, et al. CD4 lymphocytopenia as a risk factor for skin cancers in renal transplant recipients. Transplantation 1998; 65: 1270-2. (Pubitemid 28224350)
27. Mellstedt H, Choudhury A,. T and B cells in B-chronic lymphocytic leukaemia: Faust, Mephistopheles and the pact with the Devil. Cancer Immunol Immunother 2006; 55: 210-20. (Pubitemid 41682593)
28. Wilkins K, Turner R, Dolev JC, et al. Cutaneous malignancy and human immunodeficiency virus disease. J Am Acad Dermatol 2006; 54: 189-206. (Pubitemid 43144386)
29. Grulich AE, van Leeuwen MT, Falster MO, et al. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007; 370: 59-67. (Pubitemid 47017468)
30. Engels EA, Biggar RJ, Hall HI, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 2008; 123: 187-94. (Pubitemid 351705208)
31. Lanoy E, Dores GM, Madeleine MM, et al. Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States. AIDS 2009; 23: 385-93.
32. Lanoy E, Costagliola D, Engels EA,. Skin cancers associated with HIV infection and solid-organ transplantation among elderly adults. Int J Cancer 2010; 126: 1724-31.
33. Chaturvedi AK, Madeleine MM, Biggar RJ, et al. Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst 2009; 101: 1120-30.
34. Jensen P, Hansen S, Moller B, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40: 177-86. (Pubitemid 29072794)
35. Bouwes Bavinck JN, Euvrard S, Naldi L, et al. Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in the Netherlands, United Kingdom, Germany, France, and Italy. J Invest Dermatol 2007; 127: 1647-56. (Pubitemid 46933435)
36. Struijk L, Bouwes Bavinck JN, Wanningen P, et al. Presence of human papillomavirus DNA in plucked eyebrow hairs is associated with a history of cutaneous squamous cell carcinoma. J Invest Dermatol 2003; 121: 1531-5. (Pubitemid 38005509)
37. Gassenmaier A, Fuchs P, Schell H, et al. Papillomavirus DNA in warts of immunosuppressed renal allograft recipients. Arch Dermatol Res 1986; 278: 219-23. (Pubitemid 16106521)
38. de Jong-Tieben LM, Berkhout RJ, ter Schegget J, et al. The prevalence of human papillomavirus DNA in benign keratotic skin lesions of renal transplant recipients with and without a history of skin cancer is equally high: a clinical study to assess risk factors for keratotic skin lesions and skin cancer. Transplantation 2000; 69: 44-9. (Pubitemid 30062606)
39. Boyle J, MacKie RM, Briggs JD, et al. Cancer, warts, and sunshine in renal transplant patients. A case-control study. Lancet 1984; i: 702-5.
40. Blohme I, Larko O,. Skin lesions in renal transplant patients after 10-23 years of immunosuppressive therapy. Acta Derm Venereol (Stockh) 1990; 70: 491-4. (Pubitemid 20365170)
41. Nindl I, Rosl F,. Molecular concepts of virus infections causing skin cancer in organ transplant recipients. Am J Transplant 2008; 8: 2199-204.
42. Stockfleth E, Nindl I, Sterry W, et al. Human papillomaviruses in transplant-associated skin cancers. Dermatol Surg 2004; 30: 604-9. (Pubitemid 38525889)
43. de Jong-Tieben LM, Berkhout RJ, Smits HL, et al. High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients. J Invest Dermatol 1995; 105: 367-71.
44. Feng H, Shuda M, Chang Y, et al. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008; 319: 1096-100. (Pubitemid 351300792)
45. Serraino D, Piselli P, Angeletti C, et al. Risk of Kaposi's sarcoma and of other cancers in Italian renal transplant patients. Br J Cancer 2005; 92: 572-5. (Pubitemid 40395540)
46. Guba M, Graeb C, Jauch KW, et al. Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation. Transplantation 2004; 77: 1777-82. (Pubitemid 38822196)
47. Gotti E, Remuzzi G,. Post-transplant Kaposi's sarcoma. J Am Soc Nephrol 1997; 8: 130-7. (Pubitemid 27496525)
48. Rival-Tringali AL, Euvrard S, Decullier E, et al. Conversion from calcineurin inhibitors to sirolimus reduces vascularization and thickness of post-transplant cutaneous squamous cell carcinomas. Anticancer Res 2009; 29: 1927-32.
49. Robson R, Cecka JM, Opelz G, et al. Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil. Am J Transplant 2005; 5: 2954-60. (Pubitemid 43923957)
50. Zmonarski SC, Boratynska M, Puziewicz-Zmonarska A, et al. Kaposi's sarcoma in renal transplant recipients. Ann Transplant 2005; 10: 59-65.
51. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-9.
52. Sarid R, Olsen SJ, Moore PS,. Kaposi's sarcoma-associated herpesvirus: epidemiology, virology, and molecular biology. Adv Virus Res 1999; 52: 139-232.
53. Parravicini C, Olsen SJ, Capra M, et al. Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients. Blood 1997; 90: 2826-9. (Pubitemid 27413494)
54. Cesarman E, Chang Y, Moore PS, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995; 332: 1186-91.
55. Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995; 86: 1276-80.
56. Ablashi D, Chatlynne L, Cooper H, et al. Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa. Br J Cancer 1999; 81: 893-7. (Pubitemid 29504703)
57. Simpson GR, Schulz TF, Whitby D, et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996; 348: 1133-8. (Pubitemid 26358614)
58. Calabro ML, Sheldon J, Favero A, et al. Seroprevalence of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 in several regions of Italy. J Hum Virol 1998; 1: 207-13. (Pubitemid 128543036)
59. Whitby D, Luppi M, Barozzi P, et al. Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst 1998; 90: 395-7. (Pubitemid 28131008)
60. Cattani P, Capuano M, Cerimele F, et al. Human herpesvirus 8 seroprevalence and evaluation of nonsexual transmission routes by detection of DNA in clinical specimens from human immunodeficiency virus-seronegative patients from central and southern Italy, with and without Kaposi's sarcoma. J Clin Microbiol 1999; 37: 1150-3. (Pubitemid 29140628)
61. Whitby D, Luppi M, Sabin C, et al. Detection of antibodies to human herpesvirus 8 in Italian children: evidence for horizontal transmission. Br J Cancer 2000; 82: 702-4. (Pubitemid 30085210)
62. Luppi M, Barozzi P, Santagostino G, et al. Molecular evidence of organ-related transmission of Kaposi sarcoma-associated herpesvirus or human herpesvirus-8 in transplant patients. Blood 2000; 96: 3279-81.
63. Moore PS, Chang Y,. Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin? Annu Rev Microbiol 2003; 57: 609-39. (Pubitemid 37392956)
64. Jenner RG, Boshoff C,. The molecular pathology of Kaposi's sarcoma-associated herpesvirus. Biochim Biophys Acta 2002; 1602: 1-22. (Pubitemid 34311897)
65. Vart RJ, Nikitenko LL, Lagos D, et al. Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells. Cancer Res 2007; 67: 4042-51. (Pubitemid 46815049)
66. Campistol JM, Gutierrez-Dalmau A, Torregrosa JV,. Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma. Transplantation 2004; 77: 760-2. (Pubitemid 38366986)
67. Stallone G, Schena A, Infante B, et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med 2005; 352: 1317-23. (Pubitemid 40411498)
68. Gutierrez-Dalmau A, Sanchez-Fructuoso A, Sanz-Guajardo A, et al. Efficacy of conversion to sirolimus in posttransplantation Kaposi's sarcoma. Transplant Proc 2005; 37: 3836-8. (Pubitemid 43015184)
69. al-Sulaiman MH, Mousa DH, Dhar JM, et al. Does regressed posttransplantation Kaposi's sarcoma recur following reintroduction of immunosuppression? Am J Nephrol 1992; 12: 384-6. (Pubitemid 23039917)
70. Guba M, von Breitenbuch P, Steinbauer M, et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 2002; 8: 128-35. (Pubitemid 34155123)
71. Barozzi P, Bonini C, Potenza L, et al. Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma. Transplantation 2008; 86: 738-44.
72. Weenink JJ, Groeneveld JO, de Fijter CW,. Sirolimus monotherapy for Kaposi's sarcoma in an HIV-negative patient. Lancet Oncol 2006; 7: 875-6. (Pubitemid 44464081)
73. Guenova E, Metzler G, Hoetzenecker W, et al. Classic Mediterranean Kaposi's sarcoma regression with sirolimus treatment. Arch Dermatol 2008; 144: 692-3. (Pubitemid 351724445)
74. Casper C, Krantz EM, Corey L, et al. Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial. J Infect Dis 2008; 198: 23-30. (Pubitemid 351920285)
75. Casper C, Nichols WG, Huang ML, et al. Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment. Blood 2004; 103: 1632-4. (Pubitemid 38268952)
76. Shaw RN, Arbiser JL, Offermann MK,. Valproic acid induces human herpesvirus 8 lytic gene expression in BCBL-1 cells. AIDS 2000; 14: 899-902. (Pubitemid 30303472)
77. Lechowicz M, Dittmer DP, Lee JY, et al. Molecular and clinical assessment in the treatment of AIDS Kaposi sarcoma with valproic acid. Clin Infect Dis 2009; 49: 1946-9.
78. Siegsmund M, Wayss K, Amtmann E,. Activation of latent papillomavirus genomes by chronic mechanical irritation. J Gen Virol 1991; 72: 2787-9.
79. Nafz J, Kohler A, Ohnesorge M, et al. Persistence of Mastomys natalensis papillomavirus in multiple organs identifies novel targets for infection. J Gen Virol 2007; 88: 2670-8. (Pubitemid 47555019)
80. Bouwes Bavinck JN, Plasmeijer EI, Feltkamp MC,. Beta-papillomavirus infection and skin cancer. J Invest Dermatol 2008; 128: 1355-8.
81. Little RF, Pluda JM, Wyvill KM, et al. Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcoma. Blood 2006; 107: 4650-7. (Pubitemid 43882610)
82. Little RF, Aleman K, Kumar P, et al. Phase 2 study of pegylated liposomal doxorubicin in combination with interleukin-12 for AIDS-related Kaposi sarcoma. Blood 2007; 110: 4165-71. (Pubitemid 351377778)
83. Koon HB, Bubley GJ, Pantanowitz L, et al. Imatinib-induced regression of AIDS-related Kaposi's sarcoma. J Clin Oncol 2005; 23: 982-9. (Pubitemid 46202318)
84. Cianfrocca M, Cooley TP, Lee JY, et al. Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS Malignancy Consortium Study. J Clin Oncol 2002; 20: 153-9. (Pubitemid 34032606)
85. Dezube BJ, Krown SE, Lee JY, et al. Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS Malignancy Consortium Study. J Clin Oncol 2006; 24: 1389-94. (Pubitemid 46622003)
86. Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, (eds). Field's Virology, 5th edn. Philadelphia: Lippincott Williams & Wilkins, 2006.
87. de Villiers EM, Fauquet C, Broker TR, et al. Classification of papillomaviruses. Virology 2004; 324: 17-27. (Pubitemid 38737395)
88. zur Hausen H,. Papillomaviruses in the causation of human cancers-a brief historical account. Virology 2009; 384: 260-5.
89. IARC. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 90. Human Papillomaviruses. Lyon: IARC, 2007.
90. Feltkamp MC, de Koning MN, Bavinck JN, et al. Betapapillomaviruses: innocent bystanders or causes of skin cancer. J Clin Virol 2008; 43: 353-60.
91. Bouvard V, Baan R, Straif K, et al. A review of human carcinogens-part B: biological agents. Lancet Oncol 2009; 10: 321-2.
92. Majewski S, Jablonska S,. Human papillomavirus-associated tumors of the skin and mucosa. J Am Acad Dermatol 1997; 36: 659-85. (Pubitemid 27215352)
93. de Villiers EM,. Papillomavirus and HPV typing. Clin Dermatol 1997; 15: 199-206.
94. Meyer T, Arndt R, Christophers E, et al. Frequency and spectrum of HPV types detected in cutaneous squamous-cell carcinomas depend on the HPV detection system: a comparison of four PCR assays. Dermatology 2000; 201: 204-11.
95. Lu S, Syrjanen SL, Havu VK, et al. Known HPV types have no association with keratoacanthomas. Arch Dermatol Res 1996; 288: 129-32. (Pubitemid 26093166)
96. Viviano E, Sorce M, Mantegna M,. Solitary keratoacanthomas in immunocompetent patients: no detection of papillomavirus DNA by polymerase chain reaction. New Microbiol 2001; 24: 295-7. (Pubitemid 33633225)
97. Hopfl RM, Schir MM, Fritsch PO,. Keratoacanthomas: human papillomavirus associated? Arch Dermatol 1992; 128: 563-4.
98. Mallitt KA, O'Rourke P, Bouwes Bavinck JN, et al. An analysis of clustering of betapapillomavirus antibodies. J Gen Virol 2010; 91: 2062-7.
99. Waterboer T, Neale R, Michael KM, et al. Antibody responses to 26 skin human papillomavirus types in the Netherlands, Italy and Australia. J Gen Virol 2009; 90: 1986-98.
100. Casabonne D, Waterboer T, Michael KM, et al. The seroprevalence of human papillomavirus by immune status and by ethnicity in London. Infect Agent Cancer 2009; 4: 14.
101. Casabonne D, Waterboer T, Michael KM, et al. The sero-epidemiology of human papillomavirus among caucasian transplant recipients in the UK. Infect Agent Cancer 2009; 4: 13.
102. Waterboer T, Abeni D, Sampogna F, et al. Serological association of beta and gamma human papillomaviruses with squamous cell carcinoma of the skin. Br J Dermatol 2008; 159: 457-9. (Pubitemid 352009826)
103. Struijk L, Hall L, van der Meijden E, et al. Markers of cutaneous human papillomavirus infection in individuals with tumor-free skin, actinic keratoses, and squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2006; 15: 529-35.
104. Karagas MR, Nelson HH, Sehr P, et al. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst 2006; 98: 389-95.
105. Feltkamp MC, Broer R, di Summa FM, et al. Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer. Cancer Res 2003; 63: 2695-700. (Pubitemid 36605215)
106. Casabonne D, Michael KM, Waterboer T, et al. A prospective pilot study of antibodies against human papillomaviruses and cutaneous squamous cell carcinoma nested in the Oxford component of the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2007; 121: 1862-8. (Pubitemid 47417308)
107. Casabonne D, Lally A, Mitchell L, et al. A case-control study of cutaneous squamous cell carcinoma among caucasian organ transplant recipients: the role of antibodies against human papillomavirus and other risk factors. Int J Cancer 2009; 125: 1935-45.
108. Andersson K, Waterboer T, Kirnbauer R, et al. Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions. Cancer Epidemiol Biomarkers Prev 2008; 17: 189-95. (Pubitemid 351196290)
109. Plasmeijer EI, Neale RE, O'Rourke P, et al. Lack of association between the presence and persistence of betapapillomavirus DNA in eyebrow hairs and betapapillomavirus L1 antibodies in serum. J Gen Virol 2010; 91: 2073-9.
110. Karagas MR, Waterboer T, Li Z, et al. Genus beta human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: population based case-control study. BMJ 2010; 341: c2986.
111. Wentzensen N, Vinokurova S, von Knebel Doeberitz M,. Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res 2004; 64: 3878-84. (Pubitemid 38697299)
112. Pett MR, Alazawi WO, Roberts I, et al. Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes. Cancer Res 2004; 64: 1359-68. (Pubitemid 38235604)
113. Cullen AP, Reid R, Campion M, et al. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol 1991; 65: 606-12.
114. Klaes R, Woerner SM, Ridder R, et al. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res 1999; 59: 6132-6. (Pubitemid 30035633)
115. Durst M, Bosch FX, Glitz D, et al. Inverse relationship between human papillomavirus (HPV) type 16 early gene expression and cell differentiation in nude mouse epithelial cysts and tumors induced by HPV-positive human cell lines. J Virol 1991; 65: 796-804.
116. zur Hausen H,. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000; 92: 690-8. (Pubitemid 30365529)
117. Wells SI, Francis DA, Karpova AY, et al. Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21(CIP)-dependent pathways. EMBO J 2000; 19: 5762-71.
118. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.
119. Westra WH, Taube JM, Poeta ML, et al. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck. Clin Cancer Res 2008; 14: 366-9. (Pubitemid 351226102)
120. Kusters-Vandevelde HV, van Leeuwen A, Verdijk MA, et al. CDKN2A but not TP53 mutations nor HPV presence predict poor outcome in metastatic squamous cell carcinoma of the skin. Int J Cancer 2010; 126: 2123-32.
121. Ramoz N, Taieb A, Rueda LA, et al. Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25. J Invest Dermatol 2000; 114: 1148-53. (Pubitemid 30415231)
122. Ramoz N, Rueda LA, Bouadjar B, et al. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 2002; 32: 579-81. (Pubitemid 35435168)
123. Lazarczyk M, Pons C, Mendoza JA, et al. Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J Exp Med 2008; 205: 35-42. (Pubitemid 351185713)
124. Orth G,. Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses. Semin Immunol 2006; 18: 362-74. (Pubitemid 44511885)
125. Schaper ID, Marcuzzi GP, Weissenborn SJ, et al. Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. Cancer Res 2005; 65: 1394-400. (Pubitemid 40270167)
126. Akgul B, Garcia-Escudero R, Ghali L, et al. The E7 protein of cutaneous human papillomavirus type 8 causes invasion of human keratinocytes into the dermis in organotypic cultures of skin. Cancer Res 2005; 65: 2216-23. (Pubitemid 40490130)
127. Jablonska S, Dabrowski J, Jakubowicz K,. Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Cancer Res 1972; 32: 583-9.
128. Harwood CA, McGregor JM, Proby CM, et al. Human papillomavirus and the development of non-melanoma skin cancer. J Clin Pathol 1999; 52: 249-53. (Pubitemid 29161484)
129. Marcuzzi GP, Hufbauer M, Kasper HU, et al. Spontaneous tumour development in human papillomavirus type 8 E6 transgenic mice and rapid induction by UV-light exposure and wounding. J Gen Virol 2009; 90: 2855-64.
130. Asgari MM, Kiviat NB, Critchlow CW, et al. Detection of human papillomavirus DNA in cutaneous squamous cell carcinoma among immunocompetent individuals. J Invest Dermatol 2008; 128: 1409-17. (Pubitemid 351693210)
131. Bedard KM, Underbrink MP, Howie HL, et al. The E6 oncoproteins from human betapapillomaviruses differentially activate telomerase through an E6AP-dependent mechanism and prolong the lifespan of primary keratinocytes. J Virol 2008; 82: 3894-902. (Pubitemid 351521226)
132. Jackson S, Harwood C, Thomas M, et al. Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev 2000; 14: 3065-73.
133. Thomas M, Banks L,. Inhibition of Bak-induced apoptosis by HPV-18 E6. Oncogene 1998; 17: 2943-54. (Pubitemid 29012197)
134. Iftner T, Elbel M, Schopp B, et al. Interference of papillomavirus E6 protein with single-strand break repair by interaction with XRCC1. EMBO J 2002; 21: 4741-8. (Pubitemid 34984361)
135. Giampieri S, Storey A,. Repair of UV-induced thymine dimers is compromised in cells expressing the E6 protein from human papillomaviruses types 5 and 18. Br J Cancer 2004; 90: 2203-9. (Pubitemid 38869731)
136. Nafz J, Schafer K, Chen SF, et al. A novel rodent papillomavirus isolated from anogenital lesions in its natural host. Virology 2008; 374: 186-97.
137. Amtmann E, Volm M, Wayss K,. Tumour induction in the rodent Mastomys natalensis by activation of endogenous papilloma virus genomes. Nature 1984; 308: 291-2. (Pubitemid 14132038)
138. Harwood CA, Surentheran T, McGregor JM, et al. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000; 61: 289-97. (Pubitemid 30368527)
139. Forslund O, Ly H, Reid C, et al. A broad spectrum of human papillomavirus types is present in the skin of Australian patients with non-melanoma skin cancers and solar keratosis. Br J Dermatol 2003; 149: 64-73. (Pubitemid 36966512)
140. Shamanin V, zur Hausen H, Lavergne D, et al. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst 1996; 88: 802-11. (Pubitemid 26187389)
141. Forslund O, DeAngelis PM, Beigi M, et al. Identification of human papillomavirus in keratoacanthomas. J Cutan Pathol 2003; 30: 423-9. (Pubitemid 36920922)
142. Berkhout RJ, Bouwes Bavinck JN, ter Schegget J,. Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J Clin Microbiol 2000; 38: 2087-96. (Pubitemid 30414320)
143. Shamanin V, Glover M, Rausch C, et al. Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients. Cancer Res 1994; 54: 4610-13. (Pubitemid 24276482)
144. Surentheran T, Harwood CA, Spink PJ, et al. Detection and typing of human papillomaviruses in mucosal and cutaneous biopsies from immunosuppressed and immunocompetent patients and patients with epidermodysplasia verruciformis: a unified diagnostic approach. J Clin Pathol 1998; 51: 606-10. (Pubitemid 28394254)
145. Otley CC, Coldiron BM, Stasko T, et al. Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants. Arch Dermatol 2001; 137: 459-63. (Pubitemid 32319841)
146. Campistol JM, Eris J, Oberbauer R, et al. Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation. J Am Soc Nephrol 2006; 17: 581-9.
147. Tessmer CS, Magalhaes LV, Keitel E, et al. Conversion to sirolimus in renal transplant recipients with skin cancer. Transplantation 2006; 82: 1792-3. (Pubitemid 46035669)
148. de Fijter JW,. Use of proliferation signal inhibitors in non-melanoma skin cancer following renal transplantation. Nephrol Dial Transplant 2007; 22 (Suppl. 1): i23-6.
149. Shaw M, Warren S, Groben P, et al. No evidence of Epstein-Barr virus association with Merkel cell carcinoma. J Cutan Pathol 2006; 33: 624-8. (Pubitemid 44370060)
150. Kanitakis J, Joly MO, Chouvet B, et al. Merkel cell carcinoma in immunocompetent and organ-transplant recipients do not harbor HPV. Eur J Dermatol 2006; 16: 445-6. (Pubitemid 44328994)
151. Kassem A, Schopflin A, Diaz C, et al. Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene. Cancer Res 2008; 68: 5009-13.
152. Becker JC, Houben R, Ugurel S, et al. MC polyomavirus is frequently present in Merkel cell carcinoma of European patients. J Invest Dermatol 2009; 129: 248-50.
153. Garneski KM, Warcola AH, Feng Q, et al. Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors. J Invest Dermatol 2009; 129: 246-8.
154. Shuda M, Arora R, Kwun HJ, et al. Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. Int J Cancer 2009; 125: 1243-9.
155. Busam KJ, Jungbluth AA, Rekthman N, et al. Merkel cell polyomavirus expression in Merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas. Am J Surg Pathol 2009; 33: 1378-85.
156. Foulongne V, Dereure O, Kluger N, et al. Merkel cell polyomavirus DNA detection in lesional and nonlesional skin from patients with Merkel cell carcinoma or other skin diseases. Br J Dermatol 2010; 162: 59-63.
157. Foulongne V, Kluger N, Dereure O, et al. Merkel cell polyomavirus in cutaneous swabs. Emerg Infect Dis 2010; 16: 685-7.
158. Wieland U, Mauch C, Kreuter A, et al. Merkel cell polyomavirus DNA in persons without Merkel cell carcinoma. Emerg Infect Dis 2009; 15: 1496-8.
159. Foulongne V, Kluger N, Dereure O, et al. Merkel cell polyomavirus and Merkel cell carcinoma, France. Emerg Infect Dis 2008; 14: 1491-3.
160. Tolstov YL, Pastrana DV, Feng H, et al. Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int J Cancer 2009; 125: 1250-6.
161. Pastrana DV, Tolstov YL, Becker JC, et al. Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog 2009; 5: e1000578.
162. Dworkin AM, Tseng SY, Allain DC, et al. Merkel cell polyomavirus in cutaneous squamous cell carcinoma of immunocompetent individuals. J Invest Dermatol 2009; 129: 2868-74.
163. Reisinger DM, Shiffer JD, Cognetta AB Jr, et al. Lack of evidence for basal or squamous cell carcinoma infection with Merkel cell polyomavirus in immunocompetent patients with Merkel cell carcinoma. J Am Acad Dermatol 2010; 63: 400-3.
164. Ridd K, Yu S, Bastian BC,. The presence of polyomavirus in non-melanoma skin cancer in organ transplant recipients is rare. J Invest Dermatol 2009; 129: 250-2.
165. zur Hausen A,. [Merkel cell polyomavirus in the pathogenesis of non-melanoma skin cancer]. Pathologe 2009; 30 (Suppl. 2): 217-20.
166. Kassem A, Technau K, Kurz AK, et al. Merkel cell polyomavirus sequences are frequently detected in nonmelanoma skin cancer of immunosuppressed patients. Int J Cancer 2009; 125: 356-61.
167. Tadmor T, Aviv A, Polliack A,. Merkel cell carcinoma, chronic lymphocytic leukemia and other lymphoproliferative disorders: an old bond with possible new viral ties. Ann Oncol 2011; 22: 250-6.
168. Shuda M, Feng H, Kwun HJ, et al. T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci USA 2008; 105: 16272-7.
169. Lilyestrom W, Klein MG, Zhang R, et al. Crystal structure of SV40 large T-antigen bound to p53: interplay between a viral oncoprotein and a cellular tumor suppressor. Genes Dev 2006; 20: 2373-82. (Pubitemid 44320386)
170. Houben R, Shuda M, Weinkam R, et al. Merkel cell polyomavirus infected Merkel cell carcinoma cells require expression of viral T antigens. J Virol 2010; 84: 7064-72.
171. Maurer T, Ponte M, Leslie K,. HIV-associated Kaposi's sarcoma with a high CD4 count and a low viral load. N Engl J Med 2007; 357: 1352-3. (Pubitemid 47481472)
172. Plasmeijer EI, Green AC, de Koning MN, et al. Transmission of betapapillomaviruses between domestic partners in an Australian community. J Clin Virol 2010; 47: 216-18.
173. AJCC. Merkel Cell Carcinoma. American Joint Committee on Cancer Staging Manual, 7th edn. New York: Springer, 2010.
174. Grosse S,. HPV researchers set sights on preventing skin cancers. Nat Med 2009; 15: 1.